The Psychiatry Reimbursement Landscape
The commercial network is thin. The economics have moved out-of-network — and into new codes.
Psychiatry is the specialty payers under-network and under-price — which is precisely why parity law, cash economics, interventional programs, and Collaborative Care decide the margin.
Chronically low managed-care participation and depressed office E/M and psychotherapy allowables have pushed a large share of psychiatric care out-of-network and into self-pay. That reality is a liability only if it is left unmanaged: the Mental Health Parity & Addiction Equity Act (MHPAEA), and the enforcement pressure behind it, gives psychiatric providers a credible lever to press for network access and reimbursement on par with medical/surgical benefits.
Meanwhile the revenue base is broadening. Interventional psychiatry — transcranial magnetic stimulation (TMS), esketamine (Spravato) buy-and-bill, and ECT — is now material, growth-stage revenue, and the Collaborative Care Model (CoCM) and behavioral-health-integration codes let physician-led groups monetize population psychiatry through recurring, per-patient payments. Telehealth remains outsized in psychiatry and a persistent scope of substance-use and addiction treatment adds further volume. The same clinical footprint can be worth dramatically different amounts depending on how it is coded, contracted, and built out — and that is exactly where Fulcrum works. This physician-led psychiatric focus complements Fulcrum's Behavioral Health→ practice serving facility-based and program operators.
Illustrative composition. Replace with your confirmed figures before launch; reflects current CMS methodology, MHPAEA guidance, and public payer data, 2024–2026.